The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
I'll sit this one out..
but no comments...
Nice rise..
Good spot! Haha, it just goes to show how easily the obvious can be overlooked by an old fool. Nevertheless, I'm sure that we're still on to a good thing with ADI and the share price is going to do it's thing regardless of our opinions. Good luck to all on board and all the best for the coming year.
"Crop health specialist Plant Impact PLC (LON:PIM) said apart from its continued focus in the "near" markets of the UK, Netherlands, France and Germany, it also expects to grow its business in the 2012 calendar year into the US turf market via its strategic partnership with Arysta LifeScience, targeting the golf course market there. The comments came as the company, which develops and markets crop yield enhancing products, reported its results for the six months to September 30 2011. During the period, in May, Arysta took a 9.1 percent stake in the company at a significant premium to the share price and in August, Arysta veteran John Brubaker took over the helm as Plant Impact chief executive."
"Petra Diamonds was on sparkling form on Wednesday, after it announced its first day of dealings on the main market of the London Stock Exchange and unveiled the record sale of a blue diamond. The company said its shares will be admitted today, with a premium listing, after moving up from the junior AIM market. Petra described its step up as "another important development" in its progress, underscoring its transformation from a junior diamond exploration company to an independent diamond producer. Since 2007, Petra has acquired five important 'kimberlite pipe' diamond mines from De Beers, including Koffiefontein, Cullinan, Williamson, Kimberley Underground and Finsch. This beefed-up portfolio has seen Petra's resources rise from nine million carats to over 300 million carats, giving the group one of the world's largest diamond resources. And it kicked off its transformation with a bang after selling a 4.8 carat blue diamond for $1.45 million (£0.92 million), equivalent to $300,000 per carat, and the highest amount it has achieved per carat for any uncut diamond. The diamond, sold at Petra's most recent tender in early December, was produced from South Africa's famous Cullinan mine. Chairman Adonis Pouroilis said: "Over the last few years, Petra's rapid development has seen the company grow to become London's largest quoted diamond mining group. We have compiled a world-class portfolio of long-life assets. "Our core objective is to continue to deliver substantial growth over the coming years, as we steadily increase annual production to over five million carats by financial year 2019, placing Petra in a strong position to benefit from the long-term supply/demand fundamentals of the rough diamond market."
Sells this morning as expected. A dip will do me very nicely thank you as I'd like to top my ADIs up. Looking forward to the New Year !
It's looking like a good week for ADI but I think the coming year could prove to be very rewarding. Good luck to all on board.
Just playing the waiting game with PIM now but patience always pays. Doing rather well with ADI today, is anyone else in on those?
Would any mind if I said 'BOOOOOOOM!' ?
Hello Share Shark, the info is on Share Centre website against ADI, ref: https://www.share.com/cgi-bin/oicgi.exe/inet_tsc_dl2?pass=1&csi=14270&action=news&story_id=3184933&rns=1 Regards, EW
Stochastic analysis + media influence = good outlook for this share but how many people have actually noticed ADI?
ReGen Therapeutics Plc (AIM:RGT) are pleased to announce that the Company has received today a further order from Metagenics Inc. its distributor in the professional channel in the USA.
This Is Money article reads: "Mike Ashley’s Sports Direct has re-emerged as a potential rescue bidder for troubled camping products retailer Blacks. The board confirms that it has received an expression of interest from Sports Direct, amongst a number of others, which may or may not lead to an offer being made for the company." Mike Ashley has a 21.3 per cent stake in the company, so it's obviously more than a passing interest..
Smith & Nephew plc today announces that Ajay Piramal will join the Board as a Non-Executive Director from 1 January 2012. John Buchanan, Chairman of Smith & Nephew, commented: "Ajay brings unique and highly valuable experience to Smith & Nephew, having built a world-class medical and industrial enterprise and he is one of India's most respected businessmen. His industry and market knowledge, especially from working in locations such as India and China, will enrich the Board and help the executive team to deliver Smith & Nephew's growth plans for the emerging markets. I am delighted he is joining our Board and very much look forward to working with him."